Back to News
The article highlights two recent insider transactions, focusing on insider buying at Sensus Healthcare following an SEC filing. However, the provided excerpt is incomplete and does not include the buy size, price, or any subsequent market reaction, limiting conviction on potential impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
SRTS0.00
More News
- First Guaranty Bancshares director Smith buys $822,013 in stock
- On Semiconductor group president Sudhir Gopalswamy sells $1.25m in shares
- Verisk analytics CFO Elizabeth Mann sells $73,940 in stock
- General American Investors Financial Chief Purchases $71,040 Preferred Stock. Is This Closed-End Fund a Bargain?
- Gentoo Media notification of trade
- HYLN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Hyliion Investors of Securities Class Action Lawsuit Deadline on October 27, 2026